References
- McCluskey PJ, Watson PG, Lightman S, et al. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology. 1999;106:2380–2386
- Fraunfelder FT, Watson PG. Evaluation of eyes enucleated for scleritis. Br J Ophthalmol. 1976;60:227–230
- Calthorpe CM, Watson PG, McCartney AC. Posterior scleritis: a clinical and histological survey. Eye (Lond). 1988;2(pt 3):267–277
- Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology. 1994;101:389–396
- Akpek EK, Thorne JE, Qazi FA, et al. Evaluation of patients with scleritis for systemic disease. Ophthalmology. 2004;111:501–506
- Papaliodis GN, Chu D, Foster CS. Treatment of ocular inflammatory disorders with daclizumab. Ophthalmology. 2003;110:786–789
- Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, et al. Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology. 2012;119:43–50
- Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516
- Raiji VR, Palestine AG, Parver DL. Scleritis and systemic disease association in a community-based referral practice. Am J Ophthalmol. 2009;148:946–950
- Cheung CM, Chee SP. Posterior scleritis in children: clinical features and treatment. Ophthalmology. 2012;119:59–65
- Wald KJ, Spaide R, Patalano VJ, et al. Posterior scleritis in children. Am J Ophthalmol. 1992;113:281–286
- Jabs DA, Mudun A, Dunn JP, Marsh MJ. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000;130(4):469–476